Stark was founded by Thierry Mathieu, a biologist, who took 15 years to co-develop Labco, number 1 for biological analysis in Europe, with more than 750 laboratories spread over 7 countries.
Labco was re-sold for €1.2 billion in 2015.
An expert in innovation in biology and biochemistry, he has unique experience as an investor and manager in European markets.
Thierry Mathieu uses his expertise to rally an international network of legal expertise, financing and management.
With a strong specialisation in life sciences, artificial intelligence and advanced computing, Stark invests in start-ups and research projects with high growth potential.
Stark exclusively supports the very first stages of development: initiation and first round, pre-clinical stages and Proof of Concepts (POC).
Beyond investment, Stark is also a genuine strategic partner, which accelerates and guides the construction of business models: scientific orientation, financing, management, networking and lobbying.
Stark is mainly active in Europe.
Thierry MATHIEU, founder of Stark co-built with a group of fellow biologists the Labco group, international leader in biological analysis through an ambitious funding strategy, a strong culture of innovation and a truly international perspective.
In the 1990s, Stark was one of the first players to invest in advanced digital technologies, with the launch of a development area devoted to virtual reality and human-machine interfaces.
Wilkins Avenue is a production company specialising in augmented and virtual reality. At the crossroads of the worlds of entertainment and technology, it develops innovative immersive experiences. Wilkins Avenue is led by a former virtual reality leader for the Webedia group.